Skip to main content
Log in

Maltodextrins as Lyoprotectants in the Lyophilization of a Model Protein, LDH

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. Maltodextrins, partially hydrolysed starches, were evaluated as potential lyoprotectants and the effect of combinations of maltodextrins and PEG 8000 on the protection of lactate dehydro genase (LDH) was examined.

Methods. LDH activity assays were performed immediately before freezing and after reconstitution. The activity recovery was used as the parameter to evaluate the lyoprotectants. Differential Scanning Calorimetry (DSC) was used to measure the glass transition temperature (Tg′) of the solutions. DSC and X ray diffraction were used to characterise the freeze-dried products.

Results. Maltodextrins were found to protect LDH againt inactivation during freeze-drying. The lyoprotection obtained by these maltodextrins is dependent on their D.E. value and the concentration used. The maltodextrin formulations performed as good or better than those containing sucrose and maltose, depending on the concentration used. Freeze dried cakes of maltodextrin formulations were amorphous. In the case of low D.E. maltodextrins, lyoprotection was improved by the addition of PEG 8000 as a cryoprotectant.

Conclusions. Maltodextrins could be considered as potential lyoprotectants in lyophilization of proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. C. Manning, Kamlesh Patel and Ronald T. Borchardt. Stability of Protein Pharmaceuticals. Pharm. Res., 6, 903–918 (1989).

    Google Scholar 

  2. Michael J. Pikal. Freeze-Drying of Proteins. Part II: Formulation Selection. Pharmaceutical Technology International, 1991, pp.40–43.

  3. Arno T.P. Skrabanja, A.L.J. De Meere, R.A. De Ruiter and P.J.M. Van den Oetelaar. Lyophilization of Biotechnology Products. J. Parent. Sci. Technol., 48, 311–317 (1994).

    Google Scholar 

  4. Sandeep Nema and Kenneth E. Avis. Freeze-thaw studies of a model protein, lactate dehydrogenase, in the presence of cryoprotectants. J.Parent. Sci.Technol., 47, 76–83(1993).

    Google Scholar 

  5. J.F. Carpenter, S.J. Prestrelski and T. Arakawa. Separation of freezing-and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzyme Activity and Calorimetric Studies. Arch. Biochem. Biophys., 303, 456–464 (1993).

    Google Scholar 

  6. J.F. Carpenter, T. Arakawa and J.H. Crowe. Interactions of stabilizing additives with proteins during freeze-thawing and freeze-drying. Develop. Biol. Standard., 74, 225–239 (1991).

    Google Scholar 

  7. J.F. Carpenter L.M. Crowe and J.H. Crowe. Stabilization of phosphofructokinase with sugars during freeze-drying: characterization of enhanced protection in the presence of divalent cations. Biochim.Biophys.Acta, 923, 109–115 (1987).

    Google Scholar 

  8. J.F. Carpenter and J.H. Crowe. An infrared spectroscopic study of the interactions of carbohydrates with dried proteins. Biochemistry, 28, 3916–3922 (1989).

    Google Scholar 

  9. Michael W. Townsend and Patrick P. DeLuca. Use of lyoprotectants in the freeze-drying of a model protein, Ribonuclease A. J. Parent. Sci.Technol., 42, 190–199 (1988).

    Google Scholar 

  10. Ken-ichi Izutsu, Sumie Yoshioka and Tadao Terao. Decreased protein-stabilizing effects of cryoprotectants due to crystallisation. Pharm. Res. 10, 1232–1237, 1993.

    Google Scholar 

  11. Michael J. Pikal. Freeze-Drying of Proteins. Part I: Process Design. Pharmaceutical Technology International, 1991, pp.37–40.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corveleyn, S., Remon, JP. Maltodextrins as Lyoprotectants in the Lyophilization of a Model Protein, LDH. Pharm Res 13, 146–150 (1996). https://doi.org/10.1023/A:1016006106821

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016006106821

Navigation